The Australian Sustainable Finance Institute has launched a taxonomy to clarify what investment activities qualify for ‘green’ or ‘transition’ labels, but investors will still need to assess the true ...

Terrana Biosciences will develop crop protection inputs using RNA technology, which was used by Flagship portfolio company Moderna to develop its covid-19 vaccine.

The Australian investment manager plans to double down on its water strategy, with a US-dollar feeder fund in the works.